Back
Henry Schein, Inc. (HSIC)
Health CareHSIC · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$83.86
+0.77%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$3.27
ROE
8.8%
Gross margin
31.2%
Debt/Equity
0.78x
Revenue growth
6.3%
Henry Schein, Inc. — company intelligence
Earnings surprises
Q1 2026$1.32 vs $1.24 est+6.3%
Q4 2025$1.34 vs $1.33 est+1.1%
Q3 2025$1.38 vs $1.30 est+5.8%
Q2 2025$1.10 vs $1.22 est-9.5%
Analyst consensus · 24 analysts
14 Buy9 Hold1 Sell
Updated Jul 6, 2026
Insider activity · 90 days
2 buys0 sellsnet +12,215 shares
DANIEL WILLIAM KBuy 2,215 · Jun 12, 2026
BERGMAN STANLEY Mgift 50 · May 26, 2026
BERGMAN STANLEY Mgift 50 · May 21, 2026
Recent SEC filings
4 — Insider transaction reportJun 15, 2026
8-K — Material event reportMay 22, 2026
4 — Insider transaction reportMay 22, 2026
Latest news
Is Henry Schein (HSIC) Stock Undervalued Right Now? — Yahoo · 3d ago
Trucordia Welcomes Steve Roberts as Executive Vice President, Health Benefits & Financial Services — Yahoo · 3d ago
GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide — Yahoo · 1w ago
3 Reasons to Avoid HSIC and 1 Stock to Buy Instead — Yahoo · 2w ago
Is Henry Schein Stock Underperforming the Nasdaq? — Yahoo · 2w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Henry Schein, Inc.
Weekly undervalued picks (like HSIC)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.